Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (101-110 of 335) with videos related to

Pageof 34
Sort By:
Rheumatology (Oxford, England)|December 1, 2021
Purinergic signalling in systemic sclerosisJakob Höppner, Cosimo Bruni, Oliver Distler, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2004
Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditisOlga Kordonouri, Kathrin Meyer, Karl Egerer, et al.
Arthritis and Rheumatism|January 31, 2002
Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destructionChristian Kaps, Carsten Bramlage, Heike Smolian, et al.
Arthritis and Rheumatism|January 1, 2009
CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in micePaula Kolar, Karin Knieke, J Kolja E Hegel, et al.
Blood|September 8, 2012
Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopeniaCapucine Daridon, Christoph Loddenkemper, Simone Spieckermann, et al.
Advances in Therapy|November 22, 2019
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated AnalysisGerd R Burmester, Kenneth B Gordon, James T Rosenbaum, et al.
Arthritis Research & Therapy|July 25, 2006
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II studySerge D Steinfeld, Laure Tant, Gerd R Burmester, et al.
Plos One|May 7, 2013
Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, GermanyUlrich Thiem, Rainer Lamsfuß, Sven Günther, et al.
Annals of the Rheumatic Diseases|June 25, 2016
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritisGerd R Burmester, Robert Landewé, Mark C Genovese, et al.
Annals of the Rheumatic Diseases|June 11, 2014
Response to H Zeidler's comments on the CONCERTO studyGerd R Burmester, Alan Kivitz, Hartmut Kupper, et al.
Pageof 34

Showing results (101-110 of 335) with videos related to

Sort By:
Pageof 34
Rheumatology (Oxford, England)|December 1, 2021
Purinergic signalling in systemic sclerosisJakob Höppner, Cosimo Bruni, Oliver Distler, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2004
Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditisOlga Kordonouri, Kathrin Meyer, Karl Egerer, et al.
Arthritis and Rheumatism|January 31, 2002
Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destructionChristian Kaps, Carsten Bramlage, Heike Smolian, et al.
Arthritis and Rheumatism|January 1, 2009
CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in micePaula Kolar, Karin Knieke, J Kolja E Hegel, et al.
Blood|September 8, 2012
Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopeniaCapucine Daridon, Christoph Loddenkemper, Simone Spieckermann, et al.
Advances in Therapy|November 22, 2019
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated AnalysisGerd R Burmester, Kenneth B Gordon, James T Rosenbaum, et al.
Arthritis Research & Therapy|July 25, 2006
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II studySerge D Steinfeld, Laure Tant, Gerd R Burmester, et al.
Plos One|May 7, 2013
Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, GermanyUlrich Thiem, Rainer Lamsfuß, Sven Günther, et al.
Annals of the Rheumatic Diseases|June 25, 2016
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritisGerd R Burmester, Robert Landewé, Mark C Genovese, et al.
Annals of the Rheumatic Diseases|June 11, 2014
Response to H Zeidler's comments on the CONCERTO studyGerd R Burmester, Alan Kivitz, Hartmut Kupper, et al.
Pageof 34